Insight Molecular Diagnostics Inc. (IMDX)

IMDX Revenue

Insight Molecular Diagnostics had revenue of $32.00K in the quarter ending March 31, 2026, a decrease of -98.50%. This brings the company's revenue in the last twelve months to $1.95M, down -49.28% year-over-year. In the year 2025, Insight Molecular Diagnostics had annual revenue of $4.06M with 115.58% growth.

• Revenue (ttm): $1.95M
• Revenue Growth: -49.28%
• P/S Ratio: 95.10
• Revenue / Employee: $33,603
• Employees: 58
• Market Cap: 185.35M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.06M	2.17M	115.58%
Dec 31, 2024	1.88M	378.00K	25.15%
Dec 31, 2023	1.50M	545.00K	56.89%
Dec 31, 2022	958.00K	-1.24M	-56.41%
Dec 31, 2021	2.20M	982.00K	80.76%
Dec 31, 2020	1.22M	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-

Data Source: Fiscal.ai Last updated: May 13, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 29, 2026

Data Sources Report a data error